Interactions of antibody derivatives with target and effector cell surfaces

Interactions of antibody derivatives with target and effector cell surfaces

Bibliographic Details
Main Author:	Curnow, Stephen John
Published:	University of Southampton 1991
Subjects:	610 Immunotherapy
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.316375

Similar Items

Antibody derivatives for mediating cellular cytotoxicity via the Fc#gamma# receptors
by: Greenman, John
Published: (1990)

Production and characterisation of novel human monoclonal antibodies against malignant melanoma
by: Thomas, Myles Duncan
Published: (1995)

Antibody-dependent destruction of neoplastic cells by celluar effectors
by: Dearman, Rebecca Jane
Published: (1988)

Modulation of human TH cell functions by altered peptide ligands
by: Tsitoura, Daphne-Chryssoula
Published: (1996)

Thyrocytes as effectors and targets of the autoimmune response
by: Hammond, Linda Joyce
Published: (2001)

Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs
by: Slava Stamova, et al.
Published: (2012-07-01)

Surface immunoglobulins as a target for antibody therapy
by: Abdul-Ahad, A. K.
Published: (1983)

The evaluation of a heat-killed suspension of Mycobacterium vaccae as an immunomodulating agent in the treatment of cancer
by: Baban, Babak
Published: (1998)

Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells
by: Dovile Stravinskiene, et al.
Published: (2020-12-01)

Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
by: Kevin O. Saunders
Published: (2019-06-01)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
by: Hilma J. van der Horst, et al.
Published: (2020-10-01)

Antibody targeting of phosphatidylserine for detection and immunotherapy of cancer
by: Zohar DN, et al.
Published: (2018-06-01)

Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions
by: Laura Sanz-Ortega, et al.
Published: (2019-08-01)

Production of antibodies for cell surface antigens
by: Demontrond, Isabelle
Published: (1992)

Effector cells and mechanisms in chronic spontaneous urticaria
by: Borzova, Elena
Published: (2014)

Engineered Cytokine Signaling to Improve CAR T Cell Effector Function
by: Matthew Bell, et al.
Published: (2021-06-01)

Corynebacterium parvum non-specific immunotherapy : Clinical and experimental studies
by: Mitcheson, H. D.
Published: (1984)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by: Rena Liu, et al.
Published: (2020-11-01)

Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting
by: Laura Sanz-Ortega, et al.
Published: (2020-08-01)

Enhancing monocyte effector functions in antibody therapy against cancer
by: Fatehchand, Kavin, Fatehchand
Published: (2018)

Interaction of anti-idiotype antibodies with the surface of neoplastic lymphocytes
by: Elliott, T. J.
Published: (1986)

Interactions of macrophages with antibody-coated leukaemic cells
by: Lawson, A. D. G.
Published: (1983)

Complement, antibody and phagocytic cell interaction in disease
by: Clarke, J.
Published: (1980)

Strategies to Obtain Tumor-Reactive Cells for Cancer Immunotherapy by Cell Sorting and Genetic Modifications of T Lymphocytes
by: Garcia Guerrero, Estefania
Published: (2017)

Characterisation of a novel type 2 immune effector cell
by: Neill, Daniel Robert
Published: (2010)

Eradication of Established Murine Skin Tumors by Cyclic Chemoimmunotherapy with Cyclophosphamide and Effector T Cells
by: Koh Nakata, et al.
Published: (2011-01-01)

Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors
by: Jung-Won Choi, et al.
Published: (2020-11-01)

T cell effector mechanisms in experimental autoimmune uveitis (EAU)
by: Zhao, Zi-Shan
Published: (1995)

Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells
by: Gorjana Rackov, et al.
Published: (2020-08-01)

Adenoviral targeting with antibody fusion proteins
by: Watkins, Sarah Jane
Published: (1998)

Role of provision of costimulation and soluble inhibitory factors on immune responses to myeloid leukaemia
by: Buggins, Andrea Gail Sherman
Published: (1999)

Optical Control of CD8+ T Cell Metabolism and Effector Functions
by: Andrea M. Amitrano, et al.
Published: (2021-06-01)

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
by: Faroogh Marofi, et al.
Published: (2021-03-01)

CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
by: Amelia Roman Aguilera, et al.
Published: (2018-05-01)

Antibody-mediated targeting of the transferrin receptor in cancer cells
by: Rosendo Luria-Pérez, et al.
Published: (2016-11-01)

Anti-regulatory T cells are natural regulatory effector T cells
by: Niels Ødum
Published: (2019-10-01)

SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint
by: Emma Hajaj, et al.
Published: (2020-03-01)

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
by: Belzile O, et al.
Published: (2018-01-01)

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
by: Aaron R Lim, et al.
Published: (2020-05-01)

Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor
by: Mingpeng Fu, et al.
Published: (2019-06-01)